ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

ClinicalTrials.gov ID: NCT05135091

Public ClinicalTrials.gov record NCT05135091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 2:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study of Inhibitory Interneurons (NRTX-1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)

Study identification

NCT ID
NCT05135091
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Neurona Therapeutics
Industry
Enrollment
88 participants

Conditions and interventions

Interventions

  • NRTX-1001 Biological
  • Sham Comparator Procedure

Biological · Procedure

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 15, 2022
Primary completion
Jan 31, 2029
Completion
Aug 31, 2043
Last update posted
Mar 29, 2026

2022 – 2043

United States locations

U.S. sites
33
U.S. states
20
U.S. cities
31
Facility City State ZIP Site status
Mayo Clinic Arizona Epilepsy Center Phoenix Arizona 85054 Recruiting
Banner-University of Arizona Medical Center Tucson Comprehensive Epilepsy Program Tucson Arizona 85724-5023 Recruiting
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 Recruiting
University of Southern California Keck Hospital Los Angeles California 90033 Recruiting
University of California Los Angeles Los Angeles California 90095 Recruiting
UC Irvine Medical Center Orange California 92868 Recruiting
Stanford University Palo Alto California 94304 Recruiting
University of California Davis Sacramento California 95817 Recruiting
University of California San Diego San Diego California 92037 Recruiting
University of California San Francisco San Francisco California 94143 Recruiting
University of Colorado Anschutz Medical Campus Aurora Colorado 80045 Recruiting
George Washington University Washington D.C. District of Columbia 20037 Recruiting
University of Miami Miami Florida 33136 Recruiting
Rush University Medical Center Chicago Illinois 60612 Recruiting
University of Chicago Chicago Illinois 60637 Recruiting
University of Iowa Health Care Iowa City Iowa 52242 Recruiting
Ochsner Clinic Foundation New Orleans Louisiana 70121 Recruiting
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 Recruiting
Wayne State University/Detroit Medical Center Comprehensive Epilepsy Program Detroit Michigan 48201 Recruiting
Dartmouth Hitchcock Medical Center/ Department of Neurology Lebanon New Hampshire 03756 Recruiting
Hofstra Northwell Comprehensive Epilepsy Center Great Neck New York 11021 Recruiting
NYU Langone Comprehensive Epilepsy Center New York New York 10016 Recruiting
SUNY Upstate Medical University Syracuse New York 13210 Recruiting
Atrium Health Charlotte North Carolina 28204 Recruiting
Duke University Hospital Durham North Carolina 27710 Recruiting
Atrium Wake Forest Baptist Winston-Salem North Carolina 27157 Recruiting
Oregon Health and Science University Portland Oregon 97239 Recruiting
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 Recruiting
UT Southwestern Medical Center Dallas Texas 75390 Recruiting
UTHealth Houston Houston Texas 77030 Recruiting
University of Utah Health Salt Lake City Utah 84108 Recruiting
University of Washington Regional Epilepsy Center Seattle Washington 98104 Recruiting
Medical College of Wisconsin Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05135091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05135091 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →